Related Experiment Video
Updated: Jan 11, 2026

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
Published on: January 10, 2025
Multimodality Imaging in Hypertrophic Cardiomyopathy
Matthew Peters1, McKenzie Schweitzer2, Patrycja Galazka1
1Aurora Cardiovascular and Thoracic Services, Aurora Sinai/Aurora St. Luke's Medical Centers, Aurora Health Care, 2801 West Kinnickinnic River Parkway, Suite 130, Milwaukee, WI 53215, USA; Department of Cardiovascular Medicine, Wake Forest University School of Medicine, 2900 West Oklahoma Avenue, Milwaukee, WI 53215, USA.
Insights
Accurate imaging is crucial for diagnosing and managing hypertrophic cardiomyopathy (HCM). Advanced techniques like echocardiography, MRI, CT, and nuclear imaging improve risk assessment, monitoring, and treatment guidance for HCM patients.
Area of Science:
- Cardiology
- Medical Imaging
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a complex genetic heart disease.
- Accurate diagnosis and management of HCM are essential for patient outcomes.
- Traditional imaging methods have limitations in fully characterizing HCM.
Purpose of the Study:
- To review the current role of various imaging modalities in HCM.
- To highlight the complementary nature of different imaging techniques.
- To discuss emerging innovations in HCM imaging.
Main Methods:
- Review of current literature on advanced cardiovascular imaging.
- Analysis of echocardiography, cardiac magnetic resonance (CMR), computed tomography (CT), and nuclear imaging in HCM.
- Discussion of technological advancements and their clinical impact.
Main Results:
- Echocardiography provides foundational assessment of HCM.
- CMR offers superior tissue characterization and volumetric analysis.
- CT and nuclear imaging provide complementary information for specific clinical questions.
- Integrated imaging approaches enhance diagnostic accuracy and risk stratification.
Conclusions:
- Multimodality imaging is indispensable for comprehensive HCM evaluation.
- Advances in imaging are crucial for personalized risk assessment and therapy.
- Future innovations promise further refinement in HCM diagnosis and management.
Abstract:
The diagnosis and management of hypertrophic cardiomyopathy (HCM) requires accurate and comprehensive imaging. Advances in imaging technology and clinical understanding have significantly enhanced the ability to characterize the phenotype, assess risk, monitor disease progression, and guide therapy. This article highlights the complementary roles of echocardiography, cardiac magnetic resonance, computed tomography, and nuclear imaging in the evaluation of HCM and explores emerging research and innovation that are shaping future diagnostic and therapeutic strategies.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...

